13th Jan 2010 16:22
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 January 2010 of an increase in their notional interests in Ordinary shares at a price of £12.94 per share and Ordinary Share ADRs at a price of $41.48 per ADR following the notional re-investment of the dividend paid to shareholders on 7 January 2010.
|
Ordinary shares |
ADRs |
|
|
Mr A P Witty |
10,198.95 |
|
|
Mr J S Heslop |
4,995.50 |
|
|
Dr M M Slaoui |
2,618.17 |
|
|
Mrs C E Bruck Slaoui |
72.54 |
|
|
Mr S M Bicknell |
475.57 |
|
|
Mr J M Clarke |
2,865.76 |
|
|
Mrs D P Connelly |
920.23 |
|
|
Mr M Dunoyer |
1,202.46 |
|
|
Mr E J Gray |
1,363.65 |
|
|
Mr S A Hussain |
1,456.88 |
|
|
Mr D Learmouth |
790.88 |
|
|
Mr W C Louv |
948.61 |
|
|
Mr D J Phelan |
1,460.86 |
|
|
Dr D Pulman |
1,109.95 |
|
|
Mr D S Redfern |
640.89 |
|
|
Mr J R Stéphenne |
1,264.42 |
|
|
Ms C Thomas |
689.60 |
|
|
Mr D E Troy |
1,399.24 |
The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
13 January 2010
Related Shares:
Glaxosmithkline